Black Rock Inc. Harrow Health, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,148,505 shares of HROW stock, worth $73.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,148,505
Previous 2,182,758
1.57%
Holding current value
$73.5 Million
Previous $28.9 Million
55.42%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.4MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$137 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$74 Million11.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$63.9 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$25 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA723KShares$24.7 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $926M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...